CRISPR makes prostate cancer vulnerable to immunotherapy
Science News from research organizations CRISPR makes prostate cancer vulnerable to immunotherapy Date: July 26, 2026 Source: University of Rochester Medicine Summary: Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new CRISPR tool could transform hidden prostate tumors into targets the immune system can attack.
- ▪Science News from research organizations CRISPR makes prostate cancer vulnerable to immunotherapy Date: July 26, 2026 Source: University of Rochester Medicine Summary: Scientists used CRISPR to make prostate cancer cells easier for the immu
- ▪The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
- ▪Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new CRISPR tool could transform hidden prostate tumors into targets the immune system can attack.
ScienceDaily files mainly under science. We currently carry 84 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | ScienceDaily |
| Canonical URL | https://www.sciencedaily.com/releases/2026/07/260726015250.htm |
| Publication time | Sun, 26 Jul 2026 08:36:23 EDT |
| Retrieval time | 2026-07-26T13:28:04.993Z |
| Last seen | 2026-07-26T13:28:04.993Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | L32WwutFfoL1 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Science News from research organizations CRISPR makes prostate cancer vulnerable to immunotherapy Date: July 26, 2026 Source: University of Rochester Medicine Summary: Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new CRISPR tool could transform hidden prostate tumors into targets the immune system can attack. Credit: Shutterstock Prostate cancer is notoriously difficult to treat with immunotherapy, a type of cancer treatment that helps the immune system identify and destroy tumors.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at ScienceDaily.
Discussion
0 commentsMore from ScienceDaily
